1. Home
  2. LAW vs CADL Comparison

LAW vs CADL Comparison

Compare LAW & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$3.53

Market Cap

274.2M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.88

Market Cap

551.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
CADL
Founded
2013
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
274.2M
551.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LAW
CADL
Price
$3.53
$8.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$8.00
$19.00
AVG Volume (30 Days)
398.6K
2.2M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
22.58
58.62
EPS
N/A
N/A
Revenue
$156,849,000.00
$125,000.00
Revenue This Year
$11.23
N/A
Revenue Next Year
$10.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.29
N/A
52 Week Low
$2.45
$4.35
52 Week High
$9.11
$9.26

Technical Indicators

Market Signals
Indicator
LAW
CADL
Relative Strength Index (RSI) 40.12 75.99
Support Level $3.30 $4.80
Resistance Level $4.94 N/A
Average True Range (ATR) 0.40 0.52
MACD -0.09 0.18
Stochastic Oscillator 4.98 84.41

Price Performance

Historical Comparison
LAW
CADL

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: